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Abstract 
Magnetic particles (MPs) are useful tools for analyte binding and concentration, which has been extensively exploited for the 
development of electrochemical magnetosensors. Here, after binding and washing, MPs are wrapped with carbon nanotubes 
(CNT) and layered onto an electrode. In this way, CNT wiring provides signal amplification in subsequent electrochemical 
detection. We demonstrate this approach by accomplishing dopamine detection and myeloperoxidase (MPO) enzymatic activity 
monitoring. For dopamine detection, dopamine is electrostatically bound using streptavidin-MPs and for MPO enzymatic activity 
monitoring, immunofunctionalized MPs and commercially available tetramethylbenzidine-based (TMB) enzymatic substrate are 
used.   
© 2014 The Authors. Published by Elsevier Ltd. 
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1. Introduction 
MPs have been extensively used for target binding and concentration since they display high surface area which, 
when incubated under rotation with a sample, permits to capture the analyte in a more efficient way than employing 
a two-dimensional sensor surface. CNT incorporation on the electrode surface, on the other hand, increases the 
electrode roughness and effective area, provides electrocatalytic activity towards a variety of molecules and 
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improves electron transfer. In this work, the combination of the properties of MPs and CNTs is exploited for 
detection of two analytes of clinical interest, dopamine and MPO. This is performed by first capturing and 
concentrating the analyte with MPs, then wrapping these MPs with CNTs and finally confining the MP/CNT on the 
electrode surface for the electrochemical measurement [1]. 
Dopamine is a cathecolamine that acts as neurotransmitter and chemical messenger. Abnormal production of 
dopamine in the brain is associated with a number of neurological and neurodegenerative disorders, such as 
schizophrenia or Parkinson´s disease. Dopamine is found in urine of healthy individuals at high nM concentrations 
and is usually detected using sensitive and selective chromatographic methods, such as high performance liquid 
chromatography (HPLC) and capillary electrophoresis. Those approaches, however, depend on bulky and expensive 
equipment that has to be handled by specialized staff.  Electrochemical sensors have been proposed as a cheaper and 
simpler alternative for detection of dopamine [2].  
MPO is a cardiovascular biomarker and its monitoring has been defended to be a sensitive predictor of 
myocardial infarction. Moreover, it has been hypothesized [3] that, in contrast to well established biomarkers like 
(troponin T, creatine kinase MB isoforms and C-reactive protein), MPO levels identified patients at risk also in the 
absence of myocardial necrosis. To the best of our knowledge, only a few examples of electrochemical 
immunosensors have been reported for MPO detection.  
2. Materials and methods 
2.1. Chemical reagents, biocomponents and electrodes 
 
Phosphate-buffered saline (PBS, pH=7.4), dopamine hydrochloride (DA), L-ascorbic acid (AA), uric acid (UA), 
bovine serum albumin (BSA), Tween 20, 3,3´,5,5´ Tetramethylbenzidine Liquid Substrate for spectrophotometric 
measurements (TMB; ref. T0440), and carboxylated single-walled carbon nanotubes (SWCNT-COOH; >90.0% C, 
4-5 nm Φ, 0.5-1.5 μm length) were from Sigma Aldrich (Madrid, Spain). Streptavidin-coated magnetic particles 
(MP; dynabeads T1, 1 μm Φ) were from Life Technologies. 
Anti-human myeloperoxidase biotinylated monoclonal mouse antibody (anti-MPO) was produced by Hytest Ltd. 
(Turku, Finland) and myeloperoxidase protein (MPO) was provided by Abcam (Cambridge, UK).  
SWCNT-COOH were resuspended in deionized water (1 mg mL-1) and were sonicated in an S15H Elmasonic 
sonicator at 37 kHz for 1.5 h. 
Carbon screen printed electrodes (C-SPE) were obtained from DropSens (Oviedo, Spain). They displayed a 
carbon working electrode (4 mm diameter), a carbon counter electrode and a silver pseudoreference electrode.   
 
2.2. Dopamine binding and electrochemical detection by CNT wiring 
 
Incubations and washes were performed at room temperature, protected from light and under rotation (10 rpm). 
Dopamine was serially diluted in 100 μL of PBS, BSA 0.1%, tween 0.02% (PBS-BT) and each concentration 
was incubated with 12 μL of MPs (5 mg mL-1) for 30 minutes. Here, capture and concentration of dopamine from 
the sample is based on electrostatic attraction between positively charged dopamine and negatively charged 
streptavidin-coated MPs at pH=7. After incubation, MPs were washed and resuspended in 10 μL of PBS. For 
MP/SWCNT magnetic entrapment, MPs were pippeted for 20s with 4 μL of 3 times concentrated PBS and 5 μL of 
SWCNT-COOH [4] and were layered onto the sensor with the aid of a magnet. Finally, 50 μL of citrate phosphate 
buffer (pH 4.2) were placed on the C-SPE and cyclic voltammetry was performed for dopamine detection (Fig. 1a). 
  
2.3. Magneto immunoassay and chronoamperometric detection of MPO activity 
 
First, streptavidin-MPs were modified with biotinylated anti-MPO. Then, 6 μL of MP-antiMPOs (5 mg mL-1) 
were incubated with different concentrations of MPO for 15 minutes (Fig. 1b). After the incubation, the MPs were 
washed and resuspended in 10 μL of PBS, were mixed with SWCNT as described previously, and MP/SWCNT 
were magnetically confined on the electrode surface. Finally, signal stabilization was achieved in 50 μL of PBS, 
which were substituted by TMB substrate for the chronoamperometric measurement. ΔI was calculated by 
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subtracting the current measured after signal stabilization in TMB from the current measured after signal 
stabilization in PBS.  
 
 
Fig. 1. (a) Scheme of the assay procedure for DA detection; (b) Scheme illustrating MP-antiMPO production and performance of the MPO 
detection assay. 
3. Results and discussion 
3.1. Dopamine electrochemical detection in the  presence of interferents and in urine samples 
Fig. 2a displays the calibration plot obtained for dopamine measurement in PBS-BT. The assay showed linear 
response versus the logarithm of dopamine concentration in the range 0.1-5 μM, signal saturation above 50 μM, an 
LOD of 2 nM (3 σ), and LOQ of 6.6 nM (10 σ). Compared to direct detection of dopamine in solution, the 
methodology proposed in this work generated significantly higher signals, especially for the lowest concentrations 
of dopamine tested for which currents up to 10 times higher were registered  (Fig. 2b). 
 
Fig. 2. (a) Calibration plot obtained for different concentrations of dopamine in PBS-BT. (Insert) Peaks obtained for different concentrations of 
dopamine in PBS-BT and in different dilutions of urine; (b) Electrochemical detection of increasing concentrations of dopamine using C-SPE, 
either measuring dopamine in solution (light blue), or after incubation and concentration using MPs, wiring with CNT and magnetic entrapment 
of the MP/SWCNT complexes onto the working electrode (dark blue).  
 
The potential effect of interferents in dopamine detection efficiency was next analyzed. It was observed that, at 
pH 7, neither AA nor UA interfered with dopamine binding and/or detection. This was presumably due to the 
different isoelectric points of these molecules: dopamine (pI= 8.87), AA (pI= 5.40) and UA (pI= 4.10), because the 
surface of the streptavidin modified MPs was negatively charged.  
Finally, the assay was applied to dopamine detection in human urine samples. To this end, different dilutions of 
the urine samples (1:2, 1:5, 1:10 and 1:20) were spiked with increasing concentrations of dopamine. As it is shown, 
the proposed detection methodology could be operated in diluted urine samples (Fig. 2b).  
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3.2. Chronoamperometric measurements of MPO 
 
The detection of MPO is founded on its specific capture from the sample using immunofunctionalized MPs, 
coupled to chronoamperometric detection of MPO endogenous peroxidase activity employing a ready-to-use 
TMB/H2O2 enzymatic substrate (Fig. 1b). 
Fig. 3a illustrates how the wrapping of MPs with increasing amounts of SWCNT (0-4 μL) generated higher 
signals and lower LODs up to 3 μL of SWCNT. Increasing the amount of SWCNT further worsened the assay LOD.  
With the optimized conditions for MPO detection, a linear response of ΔI vs MPO concentration was obtained in the 
range 0-0.12 μg mL-1 and a polynomial trend was observed for the whole range of concentrations studied (0-4 μg 
mL-1).  Signal saturation happened above 4 μg mL-1 concentration (Fig. 3b). 
The assay was also performed in 1:10 diluted human serum samples and displayed an LOD of 5.43 ng mL-1, 
which is equivalent to 54.3 ng mL-1 in the prediluted serum. In view of these results, the current assay would allow 
discrimination between healthy individuals, which display concentrations of MPO <90 ng ml-1, and patients at risk 
of suffering a cardiovascular event (>350 ng ml-1), using cheap and disposable C-SPE and commercially available 
MP and ready-to-use enzyme substrate. 
Fig. 3. (a) Signals produced by increasing concentrations of MPO after MP binding and detection by CNT wiring using different amounts of 
CNT; (b) Calibration plot showing signals produced by increasing concentrations of MPO using 3 μL SWCNT and TMB enzymatic substrate. 
(Insert) Partial amplification of the main graph. 
4. Conclusions 
The method proposed in this work, which relies on target binding and concentration using MPs coupled to 
electrochemical detection by SWCNT wiring of the MP surface to the electrode, has been proven for the detection 
of two analytes of clinical interest: dopamine and MPO. In the case of dopamine, the assay has been applied to 
dopamine detection in diluted human urine. For MPO detection, the measurements were successfully performed in 
human serum samples, achieving an LOD low enough to discriminate between healthy individuals and patients at 
risk of suffering a cardiovascular event. 
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